Hormone Replacement Therapy and COVID-19 Outcomes in Solid Organ Transplant Recipients Compared With the General Population

    Amanda J. Vinson, Alfred Jerrod Anzalone, Makayla Schissel, Ran Dai, Evan French, Amy L. Olex, Roslyn B. Mannon, Adam B. Wilcox, Adam M. Lee, Alexis Graves, Alfred Jerrod Anzalone, Amin Manna, Amit Saha, Amy L. Olex, Andrea Zhou, Andrew E. Williams, Andrew M Southerland, Andrew T. Girvin, Anita Walden, Anjali Sharathkumar, Benjamin Amor, Benjamin Bates, Brian Hendricks, Brijesh Patel, G. Caleb Alexander, Carolyn Bramante, Cavin Ward‐Caviness, Charisse Madlock‐Brown, Christine Suver, Christopher G. Chute, Christopher Dillon, Chunlei Wu, Clare Schmitt, Cliff Takemoto, Dan Housman, Davera Gabriel, David Eichmann, Diego R. Mazzotti, Donald J. Brown, Eilis Boudreau, Elaine Hill, Elizabeth Zampino, Emily Carlson Marti, Emily Pfaff, Evan French, Farrukh M. Koraishy, Federico Mariona, Fred Prior, George Sokos, Greg S. Martin, Harold P. Lehmann, Heidi Spratt, Hemalkumar B. Mehta, Hongfang Liu, Hythem Sidky, J.W. Awori Hayanga, Jami Pincavitch, Jaylyn Clark, Jeremy Harper, Jessica Y. Islam, Jian Ge, Joel Gagnier, Joel Saltz, Joel Saltz, Johanna Loomba, John B. Buse, Jomol Mathew, Joni L. Rutter, Julie A. McMurry, Justin Guinney, Justin Starren, Karen Crowley, Katie R. Bradwell, Kellie M Walters, Ken Wilkins, Kenneth Gersing, Kenrick Cato, Kimberly Murray, Kristin Kostka, Lavance Northington, Lee Allan Pyles, Leonie Misquitta, Lesley Cottrell, Lili Portilla, Mariam Deacy, Mark M. Bissell, Marshall Clark, Mary Emmett, Mary Saltz, Matvey B. Palchuk, Melissa A. Haendel, Meredith E. Adams, Meredith Temple-O’Connor, Michael G. Kurilla, Michele Morris, Nabeel Qureshi, Nasia Safdar, Nicole Garbarini, Noha Sharafeldin, Ofer Sadan
    Image of study
    TLDR Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.
    The study involved 1135 solid organ transplant recipients (SOTRs) and 43,383 non-immunosuppressed/immunosuppressed (non-ISC) patients on hormone replacement therapy (HRT) with COVID-19. It found that HRT use was associated with a lower risk of major adverse renal or cardiac events and all secondary outcomes in non-ISC individuals. In SOTRs, HRT reduced the risk of acute kidney injury and mortality in males with COVID-19 but not in females. The study suggests that the benefits of HRT are likely mediated through an immune pathway that is inhibited in immunosuppressed transplant recipients. However, the potentially modifying effects of immunosuppression on the benefits of HRT require further investigation.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community What was your “f*ck I’m balding” story?

      in Chat  178 upvotes 2 years ago
      User noticed thinning hair at 18-19, started finasteride at 22 and minoxidil at 24, with positive results. Others shared hair loss experiences and treatments, including finasteride, minoxidil, and hair transplants.

      community I think this is my stop, gentlepeople. So long and thanks for all the data 👋

      in Transgender  2264 upvotes 8 months ago
      A user shared their successful experience with hair regrowth and transitioning from male to female using minoxidil, finasteride, Nutrafol, microneedling, and hormone replacement therapy (HRT). They expressed gratitude for the results and encouraged others to explore treatments that align with their personal goals.

      community Please stop looking for a natural way to stop your hairloss

      in Chat  247 upvotes 4 years ago
      There is no natural way to stop hair loss; pharmaceuticals like minoxidil, finasteride, and RU58841 are the only effective treatments. Some users report success with minoxidil and microneedling, while others discuss the side effects of finasteride.

      community I think we all hop on estrogen. It's the only angle

      in Satire  83 upvotes 1 year ago
      The conversation humorously discusses hair loss treatments, including Minoxidil, finasteride, RU58841, and topical 17 alpha estradiol, with some users joking about transitioning to female to avoid baldness. The overall tone is satirical, emphasizing self-acceptance and the lengths people might consider for hair restoration.

      community My Hair loss/regrowth Journey Since 2017

      in Progress Pictures  9 upvotes 1 year ago
      The user shared their hair regrowth journey since 2017, using treatments like finasteride, minoxidil, dutasteride, RU58841, microneedling, and later feminizing HRT. Significant progress was noted after starting HRT, with continued improvement in hair texture and regrowth.

    Similar Research

    5 / 1000+ results